Model DetailsLeukocyte lymphoma
Model Name |
Leukocyte lymphoma | Strain |
(C57BL/6 x C3H)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
hematopoietic neoplasm • lymphoma • all sites: lymphoma • malignant lymphoma |
Strain Synonyms |
B6C3F1 • (C57BL/6xC3H) • F1-hybrid B6C3F1 • B6C3F1 • hybrid B6C3F1 • B6C3F1 (C3H x C57B16) • B6C3F1 hybrid |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Leukocyte | Male |
9% |
2 years |
|
Mahler JF, Toxicol Pathol 1996 Nov-Dec;24(6):710-6 |
| Leukocyte | Female |
25% |
2 years |
|
Mahler JF, Toxicol Pathol 1996 Nov-Dec;24(6):710-6 |
| Leukocyte | Female |
12% (6 of 50 mice) |
103 weeks |
|
Fred C, Cancer Res 2008 Oct 1;68(19):8014-21 |
| Leukocyte | Male |
8.3% (113 of 1355 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Male |
2% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Male |
20% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Male |
5.9% (65 of 1100 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Male |
2% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Male |
16% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Female |
20.9% (283 of 1353 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Female |
6% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Female |
42% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Female |
19.9% (217 of 1092 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Female |
6% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Female |
44% |
2 years |
|
Haseman JK, Toxicol Pathol 1998 May-Jun;26(3):428-41 |
| Leukocyte | Male |
12.0% (280 of 2343 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
9% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
2% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
14% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
2% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
16% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
4% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
32% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
12% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
6% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
2% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Male |
10% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
25.1% (625 of 2486 mice) |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
20% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
10% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
30% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
28% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
34% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
31% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
8% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
62% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
23% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
18% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
34% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
19% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
10% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Female |
29% |
2 years |
|
Haseman JK, Toxicol Pathol 1984;12(2):126-35 |
| Leukocyte | Unspecified |
observed |
≥1 year |
|
Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |